Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective, multicenter study (CONDOR). Morris, M. J., Carroll, P. R., Saperstein, L., Pouliot, F., Josephson, D., Wong, J. C., Pantel, A. R., Cho, S. Y., Gage, K., Piert, M., Iagaru, A., Pollard, J. H., Wong, V., Jensen, J., Stambler, N., Gorin, M. A., Siegel, B. AMER SOC CLINICAL ONCOLOGY. 2020

View details for Web of Science ID 000560368302346